These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14535971)

  • 1. Corticosteroid use and risk of hip fracture: a population-based case-control study in Denmark.
    Vestergaard P; Olsen ML; Paaske Johnsen S; Rejnmark L; Sørensen HT; Mosekilde L
    J Intern Med; 2003 Nov; 254(5):486-93. PubMed ID: 14535971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study.
    Amiche MA; Abtahi S; Driessen JHM; Vestergaard P; de Vries F; Cadarette SM; Burden AM
    Arch Osteoporos; 2018 Mar; 13(1):30. PubMed ID: 29552730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hip fracture risk in statin users--a population-based Danish case-control study.
    Rejnmark L; Olsen ML; Johnsen SP; Vestergaard P; Sørensen HT; Mosekilde L
    Osteoporos Int; 2004 Jun; 15(6):452-8. PubMed ID: 15205716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fracture risk associated with systemic and topical corticosteroids.
    Vestergaard P; Rejnmark L; Mosekilde L
    J Intern Med; 2005 Apr; 257(4):374-84. PubMed ID: 15788008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of systemic glucocorticoids and the risk of major osteoporotic fractures in patients with sarcoidosis.
    Oshagbemi OA; Driessen JHM; Pieffers A; Wouters EFM; Geusens P; Vestergaard P; van den Bergh J; Franssen FME; de Vries F
    Osteoporos Int; 2017 Oct; 28(10):2859-2866. PubMed ID: 28638981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Glucocorticoids and Risk of Community-Acquired Staphylococcus aureus Bacteremia: A Population-Based Case-Control Study.
    Smit J; Kaasch AJ; Søgaard M; Thomsen RW; Nielsen H; Frøslev T; Schønheyder HC
    Mayo Clin Proc; 2016 Jul; 91(7):873-80. PubMed ID: 27289410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study.
    Johannesdottir SA; Horváth-Puhó E; Dekkers OM; Cannegieter SC; Jørgensen JO; Ehrenstein V; Vandenbroucke JP; Pedersen L; Sørensen HT
    JAMA Intern Med; 2013 May; 173(9):743-52. PubMed ID: 23546607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of fracture in incident multiple sclerosis patients: the Danish National Health Registers.
    Bazelier MT; Bentzen J; Vestergaard P; Stenager E; Leufkens HG; van Staa TP; de Vries F
    Mult Scler; 2012 Nov; 18(11):1609-16. PubMed ID: 22472998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids and hip fracture: a population-based case-control study.
    Hubbard RB; Smith CJ; Smeeth L; Harrison TW; Tattersfield AE
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 1):1563-6. PubMed ID: 12406825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exposure to antiepileptic drugs and the risk of hip fracture: a case-control study.
    Tsiropoulos I; Andersen M; Nymark T; Lauritsen J; Gaist D; Hallas J
    Epilepsia; 2008 Dec; 49(12):2092-9. PubMed ID: 18479399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhaled and nasal corticosteroid use and the risk of fracture.
    Suissa S; Baltzan M; Kremer R; Ernst P
    Am J Respir Crit Care Med; 2004 Jan; 169(1):83-8. PubMed ID: 14551165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Average daily glucocorticoid dose, number of prescription days, and cumulative dose in the initial 90 days of glucocorticoid therapy are associated with subsequent hip and clinical vertebral fracture risk: a retrospective cohort study using a nationwide health insurance claims database in Japan.
    Iki M; Fujimori K; Nakatoh S; Tamaki J; Ishii S; Okimoto N; Imano H; Ogawa S
    Osteoporos Int; 2024 May; 35(5):805-818. PubMed ID: 38267664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures.
    Egeberg A; Schwarz P; Harsløf T; Andersen YMF; Pottegård A; Hallas J; Thyssen JP
    JAMA Dermatol; 2021 Mar; 157(3):275-282. PubMed ID: 33471030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of high-dose intermittent systemic glucocorticoids and the risk of fracture in patients with chronic obstructive pulmonary disease.
    Oshagbemi OA; Burden AM; Shudofsky KN; Driessen JHM; Vestergaard P; Krings A; Franssen FME; van den Bergh J; de Vries F
    Bone; 2018 May; 110():238-243. PubMed ID: 29462672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case-control analysis.
    Wilson JC; Sarsour K; Collinson N; Tuckwell K; Musselman D; Klearman M; Napalkov P; Jick SS; Stone JH; Meier CR
    Semin Arthritis Rheum; 2017 Jun; 46(6):819-827. PubMed ID: 28040244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
    Baandrup L
    Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fracture risk with intermittent high-dose oral glucocorticoid therapy.
    De Vries F; Bracke M; Leufkens HG; Lammers JW; Cooper C; Van Staa TP
    Arthritis Rheum; 2007 Jan; 56(1):208-14. PubMed ID: 17195223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
    Corley DA; Kubo A; Zhao W; Quesenberry C
    Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping the prescriptiome to fractures in men--a national analysis of prescription history and fracture risk.
    Abrahamsen B; Brixen K
    Osteoporos Int; 2009 Apr; 20(4):585-97. PubMed ID: 18690484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroid Is Associated with Both Hip Fracture and Fracture-Unrelated Arthropathy.
    Kao FC; Hsu YC; Lin CJ; Lo YY; Tu YK
    PLoS One; 2017; 12(1):e0169468. PubMed ID: 28125643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.